Xu Y - Search Results

1

SELE Downregulation Suppresses Mast Cell Accumulation to Protect against Inflammatory Response in Chronic Idiopathic Urticaria.

Wang H, Xu Y, Jin M, Yuan W. Wang H, et al. Among authors: xu y. Int Arch Allergy Immunol. 2021;182(2):83-93. doi: 10.1159/000507289. Epub 2020 Dec 7. Int Arch Allergy Immunol. 2021. PMID: 33285544

2

miR-383 reduces keratinocyte proliferation and induces the apoptosis in psoriasis via disruption of LCN2-dependent JAK/STAT pathway activation.

Wang H, Xu Y, Jin M, Li H, Li S. Wang H, et al. Among authors: xu y. Int Immunopharmacol. 2021 Jul;96:107587. doi: 10.1016/j.intimp.2021.107587. Epub 2021 Apr 2. Int Immunopharmacol. 2021. PMID: 33819732

3

Childhood atopic dermatitis as a precursor for developing attention deficit/hyperactivity disorder.

Xu YC, Wang JP, Zhu WJ, Li P. Xu YC, et al. Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420962902. doi: 10.1177/2058738420962902. Int J Immunopathol Pharmacol. 2020. PMID: 33045857 Free PMC article. Review.

4

Detailed Analysis of Molecular Mechanisms in Primary and Metastatic Melanoma.

Xu Y, Mu Y, Wang L, Zhang X. Xu Y, et al. J Comput Biol. 2020 Jan;27(1):9-19. doi: 10.1089/cmb.2019.0197. Epub 2019 Aug 19. J Comput Biol. 2020. PMID: 31424282

5

Novel MicroRNA Biomarkers, miR-142-5p, miR-550a, miR-1826, and miR-1201, Were Identified for Primary Melanoma.

Xu Y, Wang L, Jiang L, Zhang X. Xu Y, et al. J Comput Biol. 2020 May;27(5):815-824. doi: 10.1089/cmb.2019.0198. Epub 2019 Sep 17. J Comput Biol. 2020. PMID: 31526187

6

Protective mechanism of GPR30 agonist G1 against ultraviolet B-induced injury in epidermal stem cells.

Zhang Y, Li L, Xu Y, Zhao X, Li F. Zhang Y, et al. Among authors: xu y. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):4165-4171. doi: 10.1080/21691401.2019.1687497. Artif Cells Nanomed Biotechnol. 2019. PMID: 31713438 Free article.

7

The positive feedback loop of RHPN1-AS1/miR-1299/ETS1 accelerates the deterioration of gastric cancer.

Ding L, Wang L, Li Z, Jiang X, Xu Y, Han N. Ding L, et al. Among authors: xu y. Biomed Pharmacother. 2020 Apr;124:109848. doi: 10.1016/j.biopha.2020.109848. Epub 2020 Jan 23. Biomed Pharmacother. 2020. PMID: 31982726 Free article.

8

Hypoxia-inducible factor-1: A potential pharmacological target to manage psoriasis.

Zhu WJ, Li P, Wang L, Xu YC. Zhu WJ, et al. Int Immunopharmacol. 2020 Sep;86:106689. doi: 10.1016/j.intimp.2020.106689. Epub 2020 Jun 22. Int Immunopharmacol. 2020. PMID: 32585606 Review.

9

LncRNA MEG3 suppressed the progression of ovarian cancer via sponging miR-30e-3p and regulating LAMA4 expression.

Liu Y, Xu Y, Ding L, Yu L, Zhang B, Wei D. Liu Y, et al. Among authors: xu y. Cancer Cell Int. 2020 May 24;20:181. doi: 10.1186/s12935-020-01259-y. eCollection 2020. Cancer Cell Int. 2020. PMID: 32489317 Free PMC article.

10

EMP3: A promising biomarker for tumor prognosis and targeted cancer therapy.

Zhu W, Song S, Xu Y, Sheng H, Wang S. Zhu W, et al. Among authors: xu y. Cancer Biomark. 2024;40(3-4):227-239. doi: 10.3233/CBM-230504. Cancer Biomark. 2024. PMID: 39213053 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83,268 results

Search Page

Filters